Mustang Bio (MBIO) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
60 Degrees Pharmaceuticals is the larger company by market cap ($3.4 million vs $3.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MBIO | SXTP |
|---|---|---|
| Share price | $0.417 | $0.9725 |
| Market cap | $3.16M | $3.42M |
| 1-day change | -7.37% | -11.59% |
| EPS (TTM) | $-0.44 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.85 | $8.62 |
| 52-week low | $0.4101 | $0.84 |
| Distance from 52-week high | -77.46% | -88.72% |
| Average volume | 29.24K | 129.77K |
| Shares outstanding | 6.73M | 3.52M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MBIO vs SXTP FAQ
Which is bigger, Mustang Bio or 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals (SXTP) is larger, with a market capitalization of $3.42M compared with $3.16M for Mustang Bio (MBIO).
Are Mustang Bio and 60 Degrees Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.